161 related articles for article (PubMed ID: 9435306)
1. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
Kornmann M; Arber N; Korc M
J Clin Invest; 1998 Jan; 101(2):344-52. PubMed ID: 9435306
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.
Kornmann M; Danenberg KD; Arber N; Beger HG; Danenberg PV; Korc M
Cancer Res; 1999 Jul; 59(14):3505-11. PubMed ID: 10416617
[TBL] [Abstract][Full Text] [Related]
3. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
[TBL] [Abstract][Full Text] [Related]
4. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.
Zhou P; Jiang W; Zhang YJ; Kahn SM; Schieren I; Santella RM; Weinstein IB
Oncogene; 1995 Aug; 11(3):571-80. PubMed ID: 7630641
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma.
Nakashima T; Clayman GL
Arch Otolaryngol Head Neck Surg; 2000 Aug; 126(8):957-61. PubMed ID: 10922227
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of pancreatic cancer cell growth in vivo using a tetracycline-inducible cyclin D1 antisense expression system.
Wang JC; Thiere M; Henne-Bruns D; Knippschild U; Kornmann M
Pancreas; 2013 Jan; 42(1):141-8. PubMed ID: 22722256
[TBL] [Abstract][Full Text] [Related]
7. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
Wang MB; Yip HT; Srivatsan ES
Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
Shintani M; Okazaki A; Masuda T; Kawada M; Ishizuka M; Doki Y; Weinstein IB; Imoto M
Anticancer Res; 2002; 22(2A):639-47. PubMed ID: 12014632
[TBL] [Abstract][Full Text] [Related]
9. [Effects of antisense cyclin D1 expressing vector on the cell growth and apoptosis of pancreatic carcinoma].
Xu Y; Liu T; Gao J
Zhonghua Bing Li Xue Za Zhi; 1998 Oct; 27(5):348-51. PubMed ID: 11245009
[TBL] [Abstract][Full Text] [Related]
10. Third place--Resident Research Competition, AAO-2000. Antisense cyclin D1 inhibits growth of head and neck cancer xenografts in nude mice.
Wang SJ; Mintz LE; Natarajan V; Lee NJ; Srivatsan ES; Wang MB
Otolaryngol Head Neck Surg; 2001 Jun; 124(6):656-62. PubMed ID: 11391257
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
12. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells.
Kleeff J; Wildi S; Kumbasar A; Friess H; Lander AD; Korc M
Pancreas; 1999 Oct; 19(3):281-8. PubMed ID: 10505759
[TBL] [Abstract][Full Text] [Related]
13. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
Chen G; Wang J; Liu Z; Kornmann M
Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
[TBL] [Abstract][Full Text] [Related]
14. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
Yasui M; Yamamoto H; Ngan CY; Damdinsuren B; Sugita Y; Fukunaga H; Gu J; Maeda M; Takemasa I; Ikeda M; Fujio Y; Sekimoto M; Matsuura N; Weinstein IB; Monden M
Clin Cancer Res; 2006 Aug; 12(15):4720-9. PubMed ID: 16899623
[TBL] [Abstract][Full Text] [Related]
15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 antisense oligonucleotide inhibits cell growth stimulated by epidermal growth factor and induces apoptosis of gastric cancer cells.
Saikawa Y; Kubota T; Otani Y; Kitajima M; Modlin IM
Jpn J Cancer Res; 2001 Oct; 92(10):1102-9. PubMed ID: 11676861
[TBL] [Abstract][Full Text] [Related]
17. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum.
Wagner M; Cao T; Lopez ME; Hope C; van Nostrand K; Kobrin MS; Fan HU; Büchler MW; Korc M
Int J Cancer; 1996 Dec; 68(6):782-7. PubMed ID: 8980184
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.
Poch B; Gansauge F; Schwarz A; Seufferlein T; Schnelldorfer T; Ramadani M; Beger HG; Gansauge S
Pancreas; 2001 Oct; 23(3):280-7. PubMed ID: 11590324
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition effect on Tca8113/CDDP by antisense oligonucleotides of cyclin D1 combined with cis diamminedichloroplatinum].
Zhou XJ; Yu Y; Pan HY; Chen WT; Zhang P; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):354-7. PubMed ID: 16836906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
